Investigating cancer drug toxicity leads to a critical discovery
When patients started showing adverse side effects during a cancer immunotherapy trial, researchers went back through the data and worked with patient samples to see what went wrong.
Materials provided by La Jolla Institute for Immunology. Original written by Madeline McCurry-Schmidt. Note: Content may be edited for style and length.
Source link aaaaa